Piper Sandler Initiates Coverage On Bioage Labs with Overweight Rating, Announces Price Target of $73

Piper Sandler analyst Yasmeen Rahimi has initiated coverage on Bioage Labs (NASDAQ: BIOA) with an Overweight rating. The firm has set a price target of $73 for the company's stock.